Research Publications

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.

Gurm HS, Lincoff AM, Kleiman NS, Kereiakes DJ, Tcheng JE, Aronow HD, Askari AT, Brennan DM, Topol EJ

Here and now--state of the art: optimal antithrombotic strategy for percutaneous coronary intervention-panel discussion.

Topol EJ, Bhatt DL, Simonton C, Steinhubl S, Lincoff AM

Coronary artery disease and the thrombospondin single nucleotide polymorphisms.

Stenina OI, Byzova TV, Adams JC, McCarthy JJ, Topol EJ, Plow EF

Role of stem cell homing in myocardial regeneration.

Penn MS, Zhang M, Deglurkar I, Topol EJ

Convergence of atherosclerosis and alzheimer's disease: Cholesterol, inflammation, and misfolded proteins.

Casserly IP, Topol EJ

Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.

Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS

Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.

Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS

Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction.

Narizhneva NV, Byers-Ward VJ, Quinn MJ, Zidar FJ, Plow EF, Topol EJ, Byzova TV

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.

Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D

Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction.

Wessel J, Topol EJ, Ji M, Meyer J, McCarthy JJ